Literature DB >> 25432928

Reforming the cancer drug fund.

Martin Buxton1, Louise Longworth1, James Raftery2, Mark Sculpher3, Adrian Towse4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25432928     DOI： 10.1136/bmj.g7276

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

1.  Regulatory withdrawal of medicines marketed with uncertain benefits: the bevacizumab case study.

Authors:  Agnes Vitry; Tuan Nguyen; Vikky Entwistle; Elizabeth Roughead
Journal:  J Pharm Policy Pract       Date:  2015-10-19

2.  Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals.

Authors:  Liz Morrell; Sarah Wordsworth; Anna Schuh; Mark R Middleton; Sian Rees; Richard W Barker
Journal:  BMC Health Serv Res       Date:  2018-05-31       Impact factor: 2.655
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.